Samuel  Behar  to  Tuberculosis Vaccines
                            
                            
                                This is a "connection" page, showing publications  Samuel  Behar  has written about  Tuberculosis Vaccines.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            3.992
         
        
        
     
 
    
        
        - 
            Behar SM, Sassetti C. Tuberculosis vaccine finds an improved route. Nature. 2020 01; 577(7788):31-32.
            
            
                Score: 0.643
             
- 
            Carpenter SM, Yang JD, Lee J, Barreira-Silva P, Behar SM. Vaccine-elicited memory CD4+ T cell expansion is impaired in the lungs during tuberculosis. PLoS Pathog. 2017 Nov; 13(11):e1006704.
            
            
                Score: 0.556
             
- 
            Carpenter SM, Nunes-Alves C, Booty MG, Way SS, Behar SM. A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during Tuberculosis. PLoS Pathog. 2016 Jan; 12(1):e1005380.
            
            
                Score: 0.488
             
- 
            Nunes-Alves C, Booty MG, Carpenter SM, Rothchild AC, Martin CJ, Desjardins D, Steblenko K, Kl?verpris HN, Madansein R, Ramsuran D, Leslie A, Correia-Neves M, Behar SM. Human and Murine Clonal CD8+ T Cell Expansions Arise during Tuberculosis Because of TCR Selection. PLoS Pathog. 2015 May; 11(5):e1004849.
            
            
                Score: 0.465
             
- 
            Nunes-Alves C, Booty MG, Carpenter SM, Jayaraman P, Rothchild AC, Behar SM. In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol. 2014 04; 12(4):289-99.
            
            
                Score: 0.429
             
- 
            Woodworth JS, Shin D, Volman M, Nunes-Alves C, Fortune SM, Behar SM. Mycobacterium tuberculosis directs immunofocusing of CD8+ T cell responses despite vaccination. J Immunol. 2011 Feb 01; 186(3):1627-37.
            
            
                Score: 0.344
             
- 
            Wu Y, Woodworth JS, Shin DS, Morris S, Behar SM. Vaccine-elicited 10-kilodalton culture filtrate protein-specific CD8+ T cells are sufficient to mediate protection against Mycobacterium tuberculosis infection. Infect Immun. 2008 May; 76(5):2249-55.
            
            
                Score: 0.283
             
- 
            Behar SM, Woodworth JS, Wu Y. Next generation: tuberculosis vaccines that elicit protective CD8+ T cells. Expert Rev Vaccines. 2007 Jun; 6(3):441-56.
            
            
                Score: 0.269
             
- 
            Lefran?ais E, Hudrisier D, Neyrolles O, Behar SM, Ernst JD. Finding and filling the knowledge gaps in mechanisms of T cell-mediated TB immunity to inform vaccine design. Nat Rev Immunol. 2025 Nov; 25(11):798-815.
            
            
                Score: 0.234
             
- 
            Boggiano C, Eichelberg K, Ramachandra L, Shea J, Ramakrishnan L, Behar S, Ernst JD, Porcelli SA, Maeurer M, Kornfeld H. "The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report. Vaccine. 2017 06 14; 35(27):3433-3440.
            
            
                Score: 0.134
             
- 
            Behar SM. Antigen-specific CD8(+) T cells and protective immunity to tuberculosis. Adv Exp Med Biol. 2013; 783:141-63.
            
            
                Score: 0.099
             
- 
            Chackerian AA, Behar SM. Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice. Tuberculosis (Edinb). 2003; 83(5):279-85.
            
            
                Score: 0.049